Precipio, Inc. (PRPO)Healthcare | Diagnostics & Research | New Haven, United States | NasdaqCM
28.30 USD
-0.27
(-0.945%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 28.30 -0.14 (-0.136%) ⇩ (April 17, 2026, 4:04 p.m. EDT) Short-term: ★★★★★ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 6:31 p.m. EDT
Strong near-term momentum driven by insider buying and significant price appreciation in April, despite high valuation; long-term outlook remains weak due to persistent losses and no dividend yield. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.061579 |
| AutoARIMA | 0.067260 |
| AutoETS | 0.069997 |
| MSTL | 0.070074 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 79% |
| H-stat | 0.29 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.174 |
| Excess Kurtosis | 0.37 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 25.088 |
| Revenue per Share | 14.983 |
| Market Cap | 50,478,200 |
| Forward P/E | 72.56 |
| Beta | 1.20 |
| Profit Margins | -1.51% |
| Website | https://www.precipiodx.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 4.4007635 |
| Address1 | 4 Science Park |
| Address2 | 3rd Floor |
| All Time High | 8,448.0 |
| All Time Low | 3.9 |
| Ask | 33.4 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 22,710 |
| Average Daily Volume3 Month | 21,804 |
| Average Volume | 21,804 |
| Average Volume10Days | 22,710 |
| Beta | 1.198 |
| Bid | 24.17 |
| Bid Size | 1 |
| Book Value | 8.176 |
| City | New Haven |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 28.3 |
| Current Ratio | 1.61 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 29.23 |
| Day Low | 28.225 |
| Debt To Equity | 25.088 |
| Display Name | Precipio |
| Dividend Date | 1,556,496,000 |
| Earnings Call Timestamp End | 1,747,342,800 |
| Earnings Call Timestamp Start | 1,747,342,800 |
| Earnings Timestamp End | 1,755,288,000 |
| Earnings Timestamp Start | 1,754,942,400 |
| Ebitda | 231,000 |
| Ebitda Margins | 0.00961 |
| Enterprise To Ebitda | 222.858 |
| Enterprise To Revenue | 2.141 |
| Enterprise Value | 51,480,200 |
| Eps Forward | 0.39 |
| Eps Trailing Twelve Months | -0.23 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 25.66768 |
| Fifty Day Average Change | 2.6323185 |
| Fifty Day Average Change Percent | 0.102553815 |
| Fifty Two Week Change Percent | 440.07635 |
| Fifty Two Week High | 29.8 |
| Fifty Two Week High Change | -1.5 |
| Fifty Two Week High Change Percent | -0.05033557 |
| Fifty Two Week Low | 5.24 |
| Fifty Two Week Low Change | 23.06 |
| Fifty Two Week Low Change Percent | 4.4007635 |
| Fifty Two Week Range | 5.24 - 29.8 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,498,829,400,000 |
| Float Shares | 1,447,012 |
| Forward Eps | 0.39 |
| Forward P E | 72.5641 |
| Free Cashflow | 210,125 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 61 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.44517 |
| Gross Profits | 10,706,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.11869001 |
| Held Percent Institutions | 0.17194 |
| Implied Shares Outstanding | 1,783,682 |
| Industry | Diagnostics & Research |
| Industry Disp | Diagnostics & Research |
| Industry Key | diagnostics-research |
| Ir Website | http://www.transgenomic.com/ir/Shareholder.asp |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,695,340,800 |
| Last Split Factor | 1:20 |
| Long Business Summary | Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut. |
| Long Name | Precipio, Inc. |
| Market | us_market |
| Market Cap | 50,478,200 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_141317959 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -363,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 50,721,138 |
| Open | 28.82 |
| Operating Cashflow | 685,000 |
| Operating Margins | 0.08091 |
| Payout Ratio | 0.0 |
| Phone | 203 787 7888 |
| Post Market Change | -0.13619995 |
| Post Market Change Percent | -0.4789668 |
| Post Market Price | 28.3 |
| Post Market Time | 1,776,456,242 |
| Previous Close | 28.57 |
| Price Hint | 2 |
| Price To Book | 3.4613504 |
| Price To Sales Trailing12 Months | 2.098973 |
| Profit Margins | -0.01509 |
| Quick Ratio | 1.235 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.27000046 |
| Regular Market Change Percent | -0.94504887 |
| Regular Market Day High | 29.23 |
| Regular Market Day Low | 28.225 |
| Regular Market Day Range | 28.225 - 29.23 |
| Regular Market Open | 28.82 |
| Regular Market Previous Close | 28.57 |
| Regular Market Price | 28.3 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 13,333 |
| Return On Assets | -0.039219998 |
| Return On Equity | -0.02724 |
| Revenue Growth | 0.229 |
| Revenue Per Share | 14.983 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 1,783,682 |
| Shares Percent Shares Out | 0.0034 |
| Shares Short | 6,065 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 3,604 |
| Short Name | Precipio, Inc. |
| Short Percent Of Float | 0.0037 |
| Short Ratio | 0.29 |
| Source Interval | 15 |
| State | CT |
| Symbol | PRPO |
| Total Cash | 2,651,000 |
| Total Cash Per Share | 1.486 |
| Total Debt | 3,653,000 |
| Total Revenue | 24,049,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.23 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 21.131245 |
| Two Hundred Day Average Change | 7.1687546 |
| Two Hundred Day Average Change Percent | 0.33924904 |
| Type Disp | Equity |
| Volume | 13,333 |
| Website | https://www.precipiodx.com |
| Zip | 6,511 |